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The present study was designed to examine the factors that motivate or act as
barriers to disclosure of substance use by pregnant women. Participants included
10 midwives and 10 pregnant women who attended two ante-natal clinics at an
Australian maternity hospital. One clinic specialized in women who were substance
users and one clinic was specifically for young women (under 19 years of age).
Midwives and pregnant women were interviewed in-depth about disclosure of
substance use. Interview transcripts were analyzed, and the results revealed six
main themes: practice style, assessment of substance use, practice environment
and privacy, child protection issues, health of the baby, and continuity of care.
The findings are discussed in relation to recommendations for best practice in
midwifery care when working with pregnant women who use substances.
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The women who use drugs and alcohol are no different
to other women; they have the same dreams and hopes as
anyone else. She wants a supportive partner, a home, a dog
in the backyard, the happy family. They are no different to
anyone else; they just have a lot more barriers getting in
the way of achieving that. (Midwife 6)
INTRODUCTION
The incidence of illicit drug use by pregnant women in Australia is between 8%
and 17% (Australian Institute of Health and Welfare [AIHW], 2003). However,
the incidence is likely to be underreported as many women do not disclose this
information to professionals. The incidence of licit drug use, including tobacco
and alcohol, is higher still. In one study, 61% of women reported smoking tobacco
and 43% of women reported drinking alcohol at some point during their pregnancy
(Clark, Dawson, & Martin, 1999).
It is known that drug use and misuse contributes to illness and disease, injury,
workplace concems, violence, crime, and breakdown in families in Australia
(Commonwealth of Australia, 2005). Pregnant women who use substances are at
risk of developing physical, mental, and social problems (Bradley, Badrinath, Bush,
Bidywickizer, & Anawalt, 1998; Lewinsohn, Rohde, & Seeley, 1996; Sarigiani,
Ryan, & Petersen, 1999; Stein & Cyr, 1997). Maternal health problems include
risks of human immunodeficiency virus transmission (Andrulis & Hopkins, 2001),
sexually transmitted diseases, hepatitis, spontaneous abortions, and malnutrition
(Little et al., 2003). Further to physical health problems, women who engage in use
of substances are also likely to be subjected to physical and sexual abuse and are
also likely to suffer severe depression (Horrigan, Schroeder, & Schaffer, 2000).
The impact on the unborn/newborn infants of women who engage in use of
substances is wide ranging (AIHW, 2003) and represents a major public and social
health problem in Australia (Alcohol and other Drugs Council of Australia, 2000;
Banwell, O'Brien, Hamilton, & Attewell, 1999). Potential health problems for the
unborn/newborn infant include withdrawal effects of substances. Illicit substances
in particular (AIHW, 2003) have an impact upon pregnancy through intra-uterine
growth retardation, risk of vertical transmission of hepatitis C virus-positive,
prematurity, low birth weight, placental abruption, congenital malformations, and
the potential for fetal death (Miller, Cox, Harbison, & Campbell, 1994). The risk of
fetal alcohol syndrome (Redding & Selleck, 1993) is a major concem when women
continue to use alcohol during pregnancy, especially during embryonic and fetal
development of early pregnancy.
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After birth, children of women who have used substances during pregnancy are
at great risk of impaired cognitive development and behavioral problems (Kukko
& Halmesmaki, 1999). The long-term effects of substance use on children also
include ineffective parenting, (Buchi, Zone, Langheinrich, & Vamer, 2003), child
abuse, poverty, and neglect (Andrulis & Hopkins, 2001).
Through early identification of substance use during pregnancy, early
implementation of treatment can reduce the harmful side effects. In tum, this can lead
to improved maternal and infant health outcomes (Armstrong et al., 2000). Early
recognition of substance use in pregnancy can also lead to improved outcomes for
unbom/newbom infants such as a longer gestational period, heavier birth weights
and better Apgar scores immediately following birth (Sweeney, Achwartz, Mattis,
& Bohr, 2000).
However, early identification of substance abuse during pregnancy is difficult
as women who use alcohol, tobacco and illicit drugs during pregnancy often have
difficulty accessing traditional systems of healthcare and disclosing their use
of substances to health professionals (Corrarino et al., 2000). Previous research
has found that pregnant women who are using alcohol and illicit drugs are most
concemed about the possibility of losing custody of their unbom infant or the custody
of their other children as seeking health care may lead to detection of substance
use (Jessup, Humphreys, Brindis, & Lee, 2003; Sword, Niccols, & Fan, 2004).
Jessup et al. (2003) reported that 78% of their sample of pregnant women who were
abusing substances highlighted fear of losing the custody of their unbom child or
police involvement were barriers to seeking health care. Fears about being judged
by health care professionals can also deter them from seeking prenatal health care
(Jessup et al., 2003).
On the other hand, fear of losing custody has also been identified as a motivating
factor for women to seek treatment for their substance use (Sword et al., 2004).
Furthermore, women may also be motivated to enter treatment for their substance
abuse or seek prenatal health care to ensure the health of their unbom baby (Corse
& Smith, 1997).
Little research has examined the barriers and motivating factors to seeking health
care and disclosing substance use for pregnant women. How to best obtain honest
information regarding substance use while maintaining an ongoing relationship with
the woman is a relevant issue for health care workers. One study found that health
professionals who provide matemity services generally fail to ask women about their
use of substances when performing their health assessments (Svikis et al., 1997).
Further research has shown that training staff to use a structured screening tool
can improve the percentage of women being screened for substance use (Kennedy,
Finklestein, Hutchins, & Mahoney, 2004). In addition, using a screening tool that
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includes more detailed questions about the frequency of use can improve disclosure
rates in comparison to a yes/no check box of use (Clark et al., 1999). Clark and
colleagues found that self-disclosure of alcoholism or drug abuse rose from 0%
using a basic screen to 6% using the detailed screening tool for a general population
of pregnant women.
Midwives are well positioned to obtain information from women related to their
lifestyle that could place them and their unbom/newbom infants at risk (McLeod
et al., 2003). The findings from an Australian study on antenatal risk assessment
indicated that midwives played a key role in the identification of psychosocial issues
for pregnant women (Willinck & Schubert, 2000). The midwives role in performing
careful and thorough health assessments of women during pregnancy can identify
whether or not women are using substances (Ettlinger, 2000). Corse and Smith
(1997) found that certified nurse-midwives in one program provided effective and
appropriate care of substance using women through comprehensive assessments,
education, intervention, and referral care.
This study examines the factors that influence self-disclosure of substance use
by pregnant women from the perspectives of both the midwife and of the pregnant
woman. The midwives were specifically interviewed about their experiences of
working with pregnant women, particularly in relation to screening for and working
with substance abuse issues. The women were interviewed about their experiences
seeking midwifery care, particularly in relation to substance use and disclosing
substance use to midwives.
METHOD
PARTICIPANTS
Ten midwives from the Royal Women's Hospital in Melboume were informed
of the study by poster information advertising it and recmited by the two on-site
research project associates. The midwives were also informed of the study by the
research assistant when she was at the hospital. Of the 10 midwives who participated,
two midwives worked in the Women's Alcohol and Dmg Service (WADS), two
midwives worked in the Young Women's Clinic (YMC), two midwives worked in the
Bookings office, and the remaining four midwives worked in two general antenatal
practice settings within the hospital. All midwives cared for pregnant women who
used or had used substances. As shown in Table 1, midwives had varying experience
ranging from four to 36 years.
Ten pregnant women were also recmited from two services within the Royal
Women's Hospital via posters advertising the study and by the research assistant.
The women were invited to participate if they met the criteria. The criteria was
that the women had to be over 18, were able to speak English, were not deemed
aggressive or substance affected on the day (as assessed by the clinic staff), and
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TABLE 1
DEMOGRAPHIC INFORMATION ABOUT MIDWIVES
Midwife 1
Midwife 2
Midwife 3
Midwife 4
Midwife 5
Midwife 6
Midwife 7
Midwife 8
Midwife 9
Midwife 10
Clinic Where Currently
Employed
General ante-natal
Booking Clinic
General ante-natal
General ante-natal
WADS
WADS
Bookings Clinic
YWC
General ante-natal
YWC
Years of Midwifery
Experience
15
32
20
9
14
22
2(H
4
12
10
TABLE 2
DEMOGRAPHIC INFORMATION ABOUT PREGNANT WOMEN
Clinic Number of Stage of
Attended Pregnancies Pregnancy
(Weeks)
Substance Use Methadone
Program
Woman 1
Woman 2
Woman 3
Woman 4
Woman 5
Woman 6
Woman 7
Woman 8
Woman 9
Woman 10
WADS
WADS
WADS
WADS
WADS
YWC
YWC
YWC
YWC
YWC
2
4
1
2
36
38
34
38
29
30
24
40
28
17
Heroin, marijuana.
tobacco
Amphetamines,
tobacco
Heroin
Alcohol, tobacco.
marijuana
Heroin
None
Ceased tobacco
Ceased alcohol
Tobacco
Ceased tobacco
Yes
No
Yes
No
Yes
No
No
No
No
No
showed interest in finding out more about the study. Table 2 shows demographic
information about the women.
Five of the 10 women who participated attended the Women's Alcohol and Drug
Service (WADS) for antenatal care. This service is specifically for pregnant women
who have been identified as having substance use issues. All five of these women
were using illicit drugs (including heroin, marijuana, and amphetamines) and four
were using tobacco and/or alcohol. Three were on the methadone program.
The remaining five women who participated in the study were recruited fi-om
the Young Women's Clinic (YWC), which was set up to support pregnant women
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aged 19 or under. While the women who attend the YWC do not necessarily have
substance use issues, substance use among young women is common. Of the five
women from the YWC, none reported using illicit substances, three reported using
tobacco, and one reported using alcohol. All women were 18 years or older and
were interviewed between 29 and 38 weeks of their pregnancy.
PROCEDURE
Invitations to both midwives and women were posted in areas where this
information would be noticed by them. The research assistant associated with this
study approached potential participants, invited their interest, informed them of
the study and then distributed a copy of the Plain Language Statement to those
potential participants who demonstrated an interest in this project. Those who
agreed to participate in the study were requested to complete the consent form,
and arrangements for an interview with each potential participate were then made.
All participants were advised that they could withdraw from the study at any time.
The response rate for both midwives and pregnant women who were invited to
participate and met the criteria was 100%. No one refused to participate and none
of the participants withdrew their participation from this study.
A semi-structured interview schedule was designed and used to obtain information
about midwives experiences and knowledge. A semi-structured interview schedule
was also designed and used to obtain information about the women's experience
with substance use and their experience of how their midwives dealt with this issue.
In both interviews, questions were asked about the assessment of substance use and
factors that facilitated or were a barrier to self disclosure of substance use.
Interview questions were unstructured and designed to promote open-ended
responses. Interviews with the midwives were between 45 minutes and an hour long.
The interviews with the pregnant women were much shorter—20 to 30 minutes.
Interviews were taped (with the consent of participant) and transcribed.
Transcripts were analyzed for main themes and then coded according to those
themes using the Nueman (2000) three phase coding system. During the first phase
of coding, the primary researcher performed an initial scan of the data, highlighting
words or phrases used by the participants and locating initial themes. Members
of the research team identified the core themes through a process of collaborative
analysis and linked the core themes to the aims of the study. In the second phase, the
researcher focused on connecting themes and finding links in the data. In the final
phase, the primary researcher reread the data and assigned excerpts that illustrate
the final themes. All coding was checked by another researcher to ensure it was
coded accurately.
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RESULTS
The analysis of interviews with midwives and pregnant women revealed six
main themes: practice style, assessment of substance use, environment and privacy
issues, child custody, health of the baby, and continuity of care. A summary of the
barrier and motivating factors to disclosure of substance use for pregnant women
is presented in Table 3.
PRACTICE STYLE
Every midwife spoke of the importance of building rapport and a sense of trust
with each woman in order to encourage disclosure of substance use. One of the main
factors described by the midwives in building rapport was having a nonjudgemental
approach towards substance use and other lifestyle factors.
I've got an attitude that is open with women... It doesn't really
bother me whether they are on dmgs or not, I won't treat them
any differently. I wouldn't judge them. (Midwife 4)
One midwife reported that her nonjudgemental attitude was maintained by her
belief that these women have disclosed their substance use, are attending WADS,
and are seeking help and seeing it as a problem. She understands that people relapse,
that abstinence is difficult, and that their lives are commonly very stressful. She
says, "I don't condone it but I understand it" (Midwife 5).
The midwives reported that it was also important to portray themselves as
supportive and caring rather than confrontational and intimidating.
I've had the occasion where the woman's absolutely stoned...
I mean she is falling asleep ... but like if you go off at her she's
not gonna come back again. (Midwife 2)
The pregnant women also highlighted that the practice style of their midwife
was important. All of the women wanted, and in the main had, midwives who were
nonjudgemental. One woman said that, "the midwives treated me with respect," and
another said "she [the midwife] talked to me, not down to me" (Woman 2).
She [the midwife] should be open minded, not judgemental,
and try to put herself in the other person's shoes. Yeah, just
don't make someone feel threatened ... that's probably best.
(Woman 3)
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She was very open and easy to talk to. (Woman 2)
Another factor that was highlighted by the midwives as important in establishing
rapport and building a trusting relationship was incorporating encouragement and
praise.
Keep going, you are growing that baby nicely. (Midwife 1)
You've been taking heroin in the past and now you are on
methadone ... this a fantastic step to take because you're not
unstable anymore. You are trying to get off heroin, you're
pregnant and this is far better for your baby than having the
highs and lows of shooting up. We commend you for coming
to the clinic and being on the program. (Midwife 4)
ASSESSMENT OF SUBSTANCE USE
All 10 midwives reported that they asked about substance use at some point in
the interview and most repeatedly asked at each visit as women may not be honest
about their substance use initially. All of the midwives agreed that questions about
substance use are received better by women if asked later in the interview after a
rapport has been established.
What I do and I encourage other people to do, is put the dmg
use aside and to make a connection with the woman first and
the rest will follow. Ifyou don't make the connection you don't
get the information.... I thitik that it is all up to me in terms
of developing that rapport and making her feel comfortable
and making her feel safe as to how much information I get.
(Midwife 6)
I think it is really important to build up a rapport with them
before you expect them to disclose something that personal.
(Midwife 9)
All of the midwives reported using the prescribed stmctured assessment form
and many find this helps them ask questions about substance use as the questions
follow a holistic assessment of the women's life circumstances.
One midwife also mentioned that she finds that the way the form is stmctured
is helpful as it leads to all questions being asked. However, a detailed history is
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uncovered before questions about substance use are asked, so a great deal is already
known and the women have relaxed a little.
When a woman has spoken of considerable stress, mental
health issues, homelessness, domestic violence, it provides
an opening for the midwife to ask about how they have coped
with such difficult circumstances, have they taken anything to
help them. (Midwife 5)
The midwives advocated for direct questions about drug use in order to get direct
and detailed responses. They suggested that there needs to be clear differentiation
between types of drugs and even how drugs are used.
Just ask them about drug use directly, don't avoid the subject,
because you can't get an answer if you don't ask them directly.
(Midwife 10)
Do you smoke tobacco? Use marijuana? If so, how much?
(Midwife 1)
Use normal language, ask them normal questions, don't try
to evade and be embarrassed and go around the questions.
They'll respect you more if you speak honestly and clearly to
them. (Midwife 9)
The women also noted the advantages of direct questions:
Well I wouldn't volunteer the information. If I'm asked a direct
question I'll give a direct answer. (Woman 2)
It's good to ask straight out because I mean to ask a question
about drug using, if you beat around the bush I think so will the
patient. As a drug user you don't really tell the truth anyway
so it's good, the more direct you are the more a person might
realize they have to be honest to themselves. (Woman 5)
However, some midwives did report finding it difficult to ask about substance use
and to differentiate between different types of drugs. Two midwives admitted that
they were not consistent in the questions they asked about substance use and would
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let the woman's age or religion infiuence them. Another midwife admitted that in
assessments she does not clarify smoking as "tobacco" or "marijuana" and she also
admits that "she is not as good with alcohol" and does not ask about that either.
I suppose I'm really at fault, I don't really ask much about alcohol
... I think too a lot of our clients are Turkish and Moslem and I
don't think alcohol figures a lot in their lifestyle. It's a cultural
thing. (Midwife 7)
On the other hand, three midwives highlighted how important it was not to make
assumptions about who might use substances.
I have been in the business long enough to know that just because
someone may not look like they are using drugs, they may in fact
be using vast quantities. The questions need to be asked. (Midwife
6)
Similarly, the women expected to be asked about their drug use, particularly
those who attended WADS:
I'd wonder what was wrong with them if they didn't ask. (Woman 2)
I had the feeling they were prying, but to make sure everything is
safe you have to tell them. (Woman 4)
THE ENVIRONMENT AND PRIVACY
Some of the midwives spoke about privacy as an issue that influenced
disclosure:
The setting in which the interview is taking place, if the door is
open or if there are just curtains portioning the various areas, they
need to know that other people aren't going to be listening to the
conversation. (Midwife 6)
The issue of privacy was further complicated when partners or family members
accompany the woman and stay with her when the assessment is being conducted.
In this sample, most women did bring someone with them to the clinic visits. While
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this support can be very important and helpful, the midwives acknowledged that
often the presence of the partner or family would inhibit disclosure of substance use,
particularly if there was domestic violence in the relationship. Midwives understand
this as an issue and develop strategies to manage this.
It will often be something they have kept from their family ... so
I'll try and ask them without a partner or someone there, just them
and I. (Midwife 9)
Two of the pregnant women also highlighted partner issues as a barrier to disclosure
of substance use. One woman talked about how she feared making her partner angry
and said, "I always thought about how it would affect him before I did answer.. .in
a couple when there are drugs and things going on, you have to hide and lie about
everything most of the time" (Woman 5). Another woman said, "I don't think you
can be honest with your partner in the room" (Woman 4).
CHILD PROTECTION ISSUES
One of the major barriers to pregnant women disclosing their substance use,
as reported by midwives, was fear of having their child taken by child protection
agencies. Three of the midwives noted that it was much easier to address this fear
and work together if the woman presented early in the pregnancy. If it was later in
the pregnancy, then women were less willing to disclose substance use due to the
fear of child protection involvement.
They are not going to divulge any more than they want you to
know, they are afraid of the consequences.. .maybe they have had
dealings with community services or had their kids taken away in
the past. (Midwife 2)
If women gave a history of say intravenous heroin using and they've
presented at the first visit say 8 to 12 weeks, it's unthreatening to talk
about it compared to talking about it at 36 weeks. (Midwife 6)
In Australia, reporting to the Department of Human Services (DHS: child
protection services) is mandatory for midwives if they fear for the child's safety.
One midwife talked about how she states this up front and then gets the woman to
plan what needs to change in order for her to be able to keep the baby safe. About
reporting, she said:
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Quite often they will be resentful to us for a couple of weeks.. .but
we keep supporting them, we keep advocating for their rights, for
them as a mother. But we are really clear that safety is paramount.
Often notification to child protection is not seen as a negative
because they receive the intensive support they need to parent
successfully. (Midwife 6)
The pregnant women also highlighted this as a real fear for them, and two of the
women reported previous DHS involvement. The issues did affect disclosure and
also the relationship with the midwife.
I was scared that if I came here they would dob me in and I would
lose my child. I wasn't sure how child welfare was involved and I
was scared of that. (Woman 3)
However, another woman actually felt pleased that the Department of Human
Services was involved as the agency put in place supports to help her.
HEALTH OF THE BABY
A main theme that emerged as a motivating factor for women to seek health
care and disclose substance use was the health of their unbom baby. As Woman 5
states, "I want more than anything to have a healthy baby and for the baby to be
safe when it is bom." This woman had undergone treatment for her addiction and
was committed to staying dmg free because of her desire for a healthy baby.
"Holding [the information] doesn't help your baby. If you say you are on 50ml of
methadone and you are actually taking 90ml, you are not helping," said Woman 1.
The fact that both the women and midwives had the health of the baby as a goal was
reassuring for the women and helped build a strong working relationship. This factor
highly influenced their ongoing attendance at the clinic. "We're sort of all working
together now to just keep clean and keep the baby healthy," said Woman 5.
CONTINUITY OF CARE
Continuity of care was highlighted by women and midwives as an important
factor. As discussed earlier, midwives reported that a good rapport and tmsting
relationship was often necessary for disclosure of substance use. However, it may
take a number of visits to establish tmst and rapport. For the women, continuity
of care was viewed as essential and also meant that they did not need to keep
retelling their story. The women at the WADS clinic did have the same caregiver,
whereas the women at the YWC clinic did not. These women received care from
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midwives working in "team midwifery," where the concept of continuity of care
is promoted.
Yeah, I explained to her [the midwife] on the phone I'm not very
good with change. I need consistency, and she's made sure that I've
had it." (Woman 2, WADS)
Ifyou see different people, different midwives each time you come
to the clinic, then they are not going to disclose anything to you, if
you see the same midwife each week then they're more likely to
disclose what they are using. (Midwife 4)
It's a pain in the bum, having to go over it every time, cause I
haven't changed, but yeah if you have a different midwife every
time how's she supposed to know what you are on since last time,
so she's gotta go back over it all. (Woman 1, YWC)
DISCUSSION
Prior research has shown that using substances during pregnancy increases the
risk of health problems for the unbom child. Through early identification of substance
use during pregnancy, access to health care and substance use treatment can reduce
harmfiil side effects and lead to improved matemal and infant health outcomes
(Armstrong et al., 2000). Midwives are well positioned to obtain information on
substance use during comprehensive health assessments (Ettlinger, 2000) and provide
appropriate ongoing care and referral to substance using women during pregnancy
(Corse & Smith, 1997).
Little research has been conducted to examine factors that motivate or act as
barriers to disclosure of substance use or to ongoing attendance at matemal health
clinics. The aim of this study was to interview midwives and pregnant women about
their knowledge and experiences to examine the factors that facilitate or are barriers
to disclosing substance use during pregnancy. Ten midwives and 10 pregnant women
were interviewed in depth.
Six main themes were identified as important in facilitating disclosure of
substance use during pregnancy. Table 3 provides an overview of the main themes
in the context of how each theme can operate as a barrier or as a motivating factor
to disclosing substance and receiving ongoing health care.
The practice style of the midwife is important in developing rapport and building
tmst. In particular, both the midwives and the pregnant women highlighted that
disclosing substance use would only occur after a tmsting relationship had been
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TABLE 3
BARRIERS AND MOTIVATING FACTORS TO DISCLOSURE OF SUBSTANCE USE FOR PREGNANT WOMEN
As a Barrier... As a Motivator...
Practice style
Judgmental;
intimidating and
confrontational.
Assessment of substance use
Relying on stereotypes — not
asking; asking vague
questions;
ask too early - without a
rapport;
not differentiating betvt'een
different substances; fail to
ask at each interview.
Environment and privacv
issues
Lack of privacy; having
another person in the room
may prevent honest
disclosure; domestic violence
may prevent honest
disclosure.
Practice stvie
Nonjudgmental; supportive and caring;
direct and honest; encouragement and
praise.
Assessment of substance use
Ask every woman about her substance use;
use structured assessment tool; use direct
questions; ask how much and how often;
repeat at each interview and probe further as
trust is built.
Environment and privacv issues
Ensure interview is conducted in a private
setting; arrange time with the woman alone
(be creative); be aware of the possibility of
domestic violence.
Child protection issues
Woman may fear that seeking
health care and disclosure of
substance use will result in
losing her child.
Health of the baby
Child protection issues
Be up front about mandatory reporting;
encourage woman to be honest about
substance use so that you can work together
towards change
Health of the baby
A main motivating factor in seeking health
care is the ultimate health of the baby;
encourage the woman to be honest about
substance use so that you can maximize
health of the baby; this should be ajoint
goal for the midwife and the woman to
work towards - helps build rapport
Continuitvofcare
Team midwifery that lacks
continuity of care may lead to
poor rapport, less disclosure,
and increased frustration for
the woman.
Referral to other services
Woman may not receive
access to substance abuse
treatment, mental health
treatment, fmancial assistance
etc.
Continuity of care
Continuity of care ensures a solid and
trusting relationship develops between the
woman and midwife; continuity of care
increases disclosure and improves outcome
Referral to other services
Midwives also need to acknowledge their
limitations and have good links with
relevant services to refer patients to for
substance abuse treatment, mental health
treatment, domestic violence counseling,
financial assistance support etc.
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established and that a nonjudgemental and supportive approach was the most
effective way to establish tmst. One explanation for this is that women fear being
judged by health professionals (Jessup et al., 2003).
Midwives reported different ways of screening for substance use. However,
the majority reported that using a screening tool and conducting a comprehensive
assessment were both important. Screening tools with specific information prompts
pertaining to substance use have been validated by prior research (Clark et al.,
1999; Kennedy et al., 2004). It appears that a more precise substance use screening
tool would guide midwives to ensure that women are questioned about their use or
nonuse of substances throughout pregnancy.
In this study, the midwives took a holistic perspective of the women. They
reported that many of the women they see who are using substances also report
abuse, mental health difficulties, and financial concems. Questions about how
women coped and whether substance use was also part of their history followed on
from assessments of the difficulties they had faced throughout their lives. Midwives
advocated for questions about substances to be asked directly, which is consistent
with the findings on asking women about their tobacco use (McLeod et al., 2003).
They were also clear that stereotyping women and making assumptions about
substance use was not helpful.
The practice environment was also shown to be important for disclosure of
substance use and particularly privacy. In relation to partners attending the health
consultations, there were two factors that may affect disclosure. Firstly, pregnant
women may not have told their partners about their substance use or the severity of
their substance use. Secondly, domestic violence was frequently reported within this
population, which may also inhibit disclosure. Previous studies have also found that
women who use substances are more likely to be subjected to physical and sexual
abuse as well as family breakdown (Commonwealth of Australia, 2005; Horrigan
et al., 2000).
The results of this study showed that the women's main concem was the health
and safety of their unbom child. In order to ensure the health of their child, the
women were willing to seek prenatal health care and disclose their substance use
history. This confirms the findings of previous studies that suggest pregnancy offers
a motivation to seek treatment for substance use (Corse & Smith, 1997; Sword et
al., 2004). The midwives also reported that this was important in order to identify
a joint goal and to establish a good working relationship with the women.
On the other hand, the women's desire for a healthy child was countered by
their fear of losing custody of their child by disclosing their substance use. Previous
studies have also found that fear of child protection involvement is a major barrier
to accessing health care and disclosure of substance use (Jessup et al., 2003; Sword
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et al., 2004). This fear is real as midwives have mandatory reporting responsibilities
according to the ACM Code of Practice for Midwives (Australian College of
Midwives Incorporated, 2001), which was adopted by the regulating authority, the
Nurses Board of Victoria. The midwives in this study were able to manage this
fear in a number of ways. Midwives reported it was important to be clear about the
mandate up front, that it was more easily managed earlier in the pregnancy, and
that they encouraged the women to come up with a plan of what needed to change
in order for the child to remain safe (and therefore child protection would not need
to be involved).
According to the midwives, continuity of care was also important in both building
a tmsting relationship and encouraging disclosure. The pregnant women also
wanted continuity of care and did not want to have to repeat their story each visit.
Continuity of care for women is generally viewed by midwives as a critical element
of woman-centered care through the provision of a known and named midwife to
provide care for women and their families (Mills, 2000). This is supported by an
Australian study conducted by Yelland, Krastev, and Brown (1999), where it was
concluded that having the same midwife was important for women during pregnancy
and prior to birth as it improved women's satisfaction with their care.
One factor that did not emerge from this study was the issue of referral for
substance use treatment. Further research is needed to examine whether midwives
are aware of other services that might be useful for women who use substances and
feel competent to refer to those services. It is important for midwives to recognize
the role and fiinction of other health professionals and to engage in a referral when
it is identified that care is becoming complex (Australian College of Midwives
Incorporated, 2001).
The strength of this study was that the use of in-depth interviewing allowed for
new themes to emerge in order to provide a more thorough understanding of the
factors that affect disclosure of substance use for pregnant women, as well as how
midwives are able to positively affect disclosure. One limitation of this study was
that the sample of pregnant women relied upon two specialized clinics, one for
women who had been identified as using substances during pregnancy, and the other
a service for young pregnant women. Therefore, it may be that the results are not
generalizable to a large proportion of pregnant women using substances who attend
mainstream clinics. In addition, the small sample may limit the generalizability of
the results, particularly in relation to ethnicity and social class, and therefore further
research is needed that incorporates a larger and more diverse sample of pregnant
women.
Overall, it is recommended that midwives working with pregnant women (of
which a proportion will be using substances) need to be more aware of issues related
372 JOURNAL OF DRUG ISSUES
DISCLOSING SUBSTANCE USE DURING PREGNANCY
to substance use during pregnancy. During every assessment, midwives should
employ a caring, supportive, and nonjudgmental practice style, assess substance
use by asking direct questions and using screening tools, ensure privacy during the
assessment, promote the health of the baby as the main goal, address child protection
issues early and honestly, and ensure continuity of care. Professional development
training on these issues relating to substance use during pregnancy would assist
midwives in providing appropriate and effective matemity services and improve
health outcomes for women who use substances during pregnancy.
REFERENCES
Andrulis, D., & Hopkins, S.
2001 Public hospitals and substance abuse services for pregnant women and
mothers: Implications for managed-care programs and Medicaid. Journal
of Urban Health, 75, 181-198.
Alcohol and other Drugs Council of Australia
2000 Drug policy 2000: A new agenda for harm reduction. Canberra: ADCA.
Armstrong, M.A., Lieberman, L., Carpenter, D.M., Gonzales, V.M., Usatin, M.S.,
Newman, L., & Escobar, G.J.
2000 Early start: An obstetric clinic-based, perinatal substance abuse intervention
program. Quality Management in Health Care, 9, 6-15.
Australian Institute of Health and Welfare
2003 National drug strategy: Statistics on drug use in Australia 2002. Canberra:
Australian Institute of Health and Welfare.
Australian College of Midwives Incorporated
2001 A CM code of practice for midwives. Canberra, Australian Capital Territory:
Australian College of Midwives Incorporated.
Banwell, C , O'Brien, M., Hamilton, M., & Attewell, R.
1999 Measuring women's alcohol consumption in an Australian inner-urban
community using the AUDIT. Drug and Alcohol Review, 18, 379-388.
Bradley, K.A., Badrinath, S., Bush, K., Bidywickizer, J., & Anawalt, B.
1998 Medical risks for women who drink alcohol. Journal of General Internal
Medicine, 13, 627-639.
Buchi, K.F., Zone, S., Langheinrich, K., & Vamer, M.W.
2003 Changing prevalence of prenatal substance abuse in Utah. The American
College of Obstetricians and Gynaecologists, 102(1), 27-30.
Clark, K.A., Dawson, S., & Martin, S.L.
1999 The effect of implementing a more comprehensive screening for substance
use among pregnant women in North Carolina. Maternal and Child Health
Journal, 5, 161-166.
SPRING 2007 373
PHILLIPS, THOMAS, COX, RICCIARDELLI, OGLE, LOVE, STEELE
Commonwealth of Australia
2005 Intergovernmental committee on drugs: National drug strategicframework
annual report 2003-04 to the ministerial council on drug strategy. Barton,
ACT: Commonwealth of Australia.
Corrarino, J.E., Williams, C, Campbell, W.S., Amrhein, E., LoPiano, L., &
Kalachik, D.
2000 Linking substance-abusing pregnant women to dmg treatment services: A
pilot program. Journal of Obstetrics Gynecology Neonatal Nursing, 29(4),
369-376.
Corse, S.J., & Smith, M.
1997 Reducing substance abuse during pregnancy: Discriminating among levels
of response in a prenatal setting. Journal of Substance Abuse Treatment,
75(5), 457-467.
Ettlinger, T.
2000 In harm's way: Recognizing and addressing alcohol risk for rural
disadvantaged pregnant mothers. Public Health Nursing, 17(3), 207-210.
Horrigan, T.J., Schroeder, A.V., & Schaffer, R.M.
2000 The triad of substance abuse, violence and depression are interrelated in
pregnancy. Journal of Substance Abuse Treatment, 18, 55-58.
Jessup, M.A., Humphreys, J.C., Brindis, CD., & Lee, K.A.
2003 Extrinsic barriers to substance abuse treatment among pregnant dmg
dependent women. Journal of Drug Issues, (33)2. Retrieved June 27,2005,
fromhttp://global.factiva.com/en/arch/print_results.asp.
Kennedy, C , Finklestein, N., Hutchins, E., & Mahoney, J.
2004 Improving screening for alcohol use during pregnancy: The Massachusetts
ASAP program. Maternal and Child Health Journal, 5(3), 137-147.
Kukko, H., & Halmesmaki, E.
1999 Prenatal care and counseling of female dmg-users: Effects of dmg abuse
and perinatal outcome. Acta Obstetrica et Gynecologica Scandinavica, 78,
22-26.
Lewinsohn, P.M., Rohde, P., & Seeley, J.R.
1996 Alcohol consumption in high school adolescents: Frequency of use and
dimensional stmcture of associated problems. Addiction, 91, 375-390.
Little, B.B., Snell, M.PH., Van Beveren, T.T., Crowell, B., Trayler, S., &
Johnston, W.L.
2003 Treatment of substance abuse during pregnancy and infant outcome.
American Journal of Perinatology, 20, 255-262.
JOURNAL OF DRUG ISSUES
DISCLOSING SUBSTANCE USE DURING PREGNANCY
McLeod, D., Benn, C, PuUon, S., Viccars, A., White, S., Cookson, T., & Dowell,
A.
2003 The midwife's role in facilitating smoking behaviour change during
pregnancy. Midwifery, 9, 285-297.
Miller, W.H., Cox, S.M., Harbison, V, & Campbell, B.A.
1994 Urine dmg screens for dmg abuse in pregnancy: Problems and pitfalls.
Women's Health Issues, 4, 152-155.
Mills, B.C.
2000 The grow1:h of human love and commitment. In L.A. Page (Ed.) & P. Percival
(Assoc. Ed.). The new midwifery: Science and sensitivity in practice (pp.
223-244). Edinburgh: Churchill Livingstone.
Nueman, W.L.
2000 Social research methods: Quantitative and qualitative approaches (5* ed.).
Boston: AUyn and Bacon.
Redding, B.A., & Selleck, C.
1993 Perinatal substance abuse: Assessment and management of the pregnant
woman and her children. Nurse Practitioner Forum, 4, 216-223.
Sarigiani, P.A., Ryan, L., & Petersen, A.C.
1999 Prevention of high-risk behaviours in adolescent women. Journal of
Adolescent Health, 25, 109-119.
Stein, M.D., & Cyr, M.G.
1997 Women and substance abuse. Alcohol and Other Substance Abuse, 81, 979-
998.
Svikis, D., Henningield, J., Gazaway, P., Huggins, G., Sosnow, K., Hrankicka, J.,
Harrow, C , & Pickens, R.
1997 Tobacco use for identifying pregnant women at risk of substance abuse.
The Journal of Reproductive Medicine, 42, 299-302.
Sweeney, P., Achwartz, R.M., Mattis, N.G., & Bohr, B.
2000 The effect of integrating substance abuse treatment with prenatal care on
birth outcome. Journal of Perinatology, 4, 219-224.
Sword, W., Niccols, A., & Fan, A.
2004 "New Choices" for women with addictions: Perceptions of program
participants. BioMed Central Public Health, 4(10), 1-11.
Willinck, L., & Schubert, R.
2000 Antenatal psychosocial risk assessment project. ACMI Journal, (3), 7-12.
Yelland, J, Krastev, A., & Brown, S.
1999 Evaluating practice and the organisation of care at Southem Health: EPOCS
Baseline Survey 1999: Women's views of matemity services. Unpublished.
Melboume, Victoria: La Trobe University.
SPRING 2007 375

